My manager worked with me and all I heard all day is increase your numbers and we don't have jobs if we don't sell, we've always been a selling organization. Show me how you're going to increase your numbers and on and on it went. Am I still going to get in trouble if I am in the red on the The Great Test?
Following COT behaviors and frequency guidance is counterproductive to selling. They do not overlap or equate to sales. The problem is leadership has redefined what performance and effective means and it has nothing to do with selling. My question is when is leadership going to address the root cause of this?
Interesting that this is the mantra now that all of the testosterone producers in leadership are gone! Who would have thought that the estrogen producers would turn out to be the meat eaters! But what about JB you ask? He has too much hair to be a testosterone producer!
Hey maybe they will start paying on sales! Oh sorry to crush your FLL and SLLs new mantra GSK cannot pay us on sales per the CIA! The mess continues. Sell the company and be done with it.
"Oh my gosh , we have to sell?!?" Are you guys f'n kidding? It's a Pharmaceutical Sales Job. It always has been. Pull your head out of the sand. We have to sell product. PERIOD. Sell Medicine so we can keep this ship sailing. If you sell and loose your job, at the very least you will be able to document your ability.
I find it ironic that no one bitches and complains about how PF and the fines came to be. The people that signed off on all of that mishegas are primarily responsible, in my opinion. Everything that has come since the big fine has been ill-conceived, but reactionary TO the fine. We're paying for the sins of those above us 10 years ago.
Great I will just sit an salivate how you idiots will go down the crapper when the dept. of health and human services enforces the cia. People to prison next time around!!
great to have no more testing but we need to relax some rules and be able to get out to dinner etc with customers and spouses , get to know family etc like most sales jobs. only problem is anoro is a niche drug , not many patients need that type of drug. breo will catch on but hoping advair also increases for company overall 2015 revenue. also hoping no generic advair till 2017.. lastly, give all the reps arnuity samples so the docs can add it on to anoro. only way for anoro to catch fire and not just be a niche drug. also hoping triple combo comes out in the fall of 2015, docs keep asking about it, cant get here fast enough.
I thought we were going to get rid of all of our speakers. Now I feel so much pressure to do program after program... What happen to Patient First, not pay my Speakers first!!!
I never even mention Arnuity. Why should I, it just further confuses my docs and can only take away from Anoro sales. We get such mixed messages from the top. No wonder we are just floundering!!!
GSK assumes and acts like anoro is a niche drug. Our competitors will position LAMA/LABA as new standard of care for COPD and show data that ICS isn't always necessary. Anoro offers defense against generic advair. Breo does not.
most primary care don't like the laba lama combo, best way to sell them is breo and incruse as a couple qd and anoro with arnuity qd so they can add the steroid..